Trials / Completed
CompletedNCT01406223
Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 282 (actual)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to look at brain function in order to understand how different treatments work to help people quit smoking. In this study, the investigators will look at the effects of nicotine patches, Chantix alone or Chantix paired with Zyban.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Varenicline | |
| DRUG | Bupropion | |
| DRUG | Nicotine patches | |
| OTHER | Placebo varenicline | |
| OTHER | Placebo bupropion | |
| OTHER | Placebo patch |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2013-12-01
- Completion
- 2014-06-01
- First posted
- 2011-08-01
- Last updated
- 2017-11-14
- Results posted
- 2017-08-31
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01406223. Inclusion in this directory is not an endorsement.